Cargando…
Matrix metalloproteinase-3 (MMP-3)–mediated gene therapy for glaucoma
Approximately 80 million people globally are affected by glaucoma, with a projected increase to over 110 million by 2040. Substantial issues surrounding patient compliance remain with topical eye drops, and up to 10% of patients become treatment resistant, putting them at risk of permanent vision lo...
Autores principales: | O’Callaghan, Jeffrey, Delaney, Conor, O’Connor, Merissa, van Batenburg-Sherwood, Joseph, Schicht, Martin, Lütjen-Drecoll, Elke, Hudson, Natalie, Ni Dhubhghaill, Sorcha, Humphries, Peter, Stanley, Chris, Keravala, Annahita, Chalberg, Thomas, Lawrence, Matthew S., Campbell, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115410/ https://www.ncbi.nlm.nih.gov/pubmed/37075118 http://dx.doi.org/10.1126/sciadv.adf6537 |
Ejemplares similares
-
Therapeutic potential of AAV-mediated MMP-3 secretion from corneal endothelium in treating glaucoma
por: O’Callaghan, Jeffrey, et al.
Publicado: (2017) -
The β(4)-Subunit of the Large-Conductance Potassium Ion Channel K(Ca)1.1 Regulates Outflow Facility in Mice
por: Bertrand, Jacques A., et al.
Publicado: (2020) -
Enhancement of Outflow Facility in the Murine Eye by Targeting Selected Tight-Junctions of Schlemm’s Canal Endothelia
por: Tam, Lawrence C. S., et al.
Publicado: (2017) -
Presbyopia and Glaucoma: Two Diseases, One Pathophysiology? The 2017 Friedenwald Lecture
por: Kaufman, Paul L., et al.
Publicado: (2019) -
Plasma Levels of Metalloproteinase 3 (MMP-3) and Metalloproteinase 7 (MMP-7) as New Candidates for Tumor Biomarkers in Diagnostic of Breast Cancer Patients
por: Ławicki, Paweł, et al.
Publicado: (2023)